[Br:1][C:2]1[S:3][C:4]([C:7]2[C:8]3[CH:15]=[CH:14][N:13](COCC[Si](C)(C)C)[C:9]=3[N:10]=[CH:11][N:12]=2)=[CH:5][N:6]=1>C(Cl)Cl.C(O)(C(F)(F)F)=O>[Br:1][C:2]1[S:3][C:4]([C:7]2[C:8]3[CH:15]=[CH:14][NH:13][C:9]=3[N:10]=[CH:11][N:12]=2)=[CH:5][N:6]=1A solution of 4-(2-bromo-1,3-thiazol-5-yl)-7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo-[2,3-d]pyrimidine (370 mg, 0.90 mmol) in DCM (5.0 mL) and TFA (1.0 mL) was stirred at room temperature for 7 hours. The mixture was then concentrated, re-dissolved in methanol (2 mL), and ethylenediamine (0.5 mL) was added. The mixture was stirred for 6 hours at room temperature. The mixture was diluted with DCM (10 mL), and the precipitate was isolated by filtration and washed with a small amount of DCM to afford desired product (182 mg, 72%).